Introduction
Peyronie's disease is a ®brotic, multifocal structural degeneration of the penile tunica albuginea, and is one of the most common causes of pathological penile bending acquired chordee. 1 ± 4 Microstructural studies have found that an inammatory perivascular process with cellular in®l-trates characterizes the initial stages of the disease, which results in excess deposition of collagen in the form of condensations that are initially ®brotic and then may become calci®c. 1, 3 Diabetes, hypertension, arthrosis, trauma, retroperitoneal ®brosis and unspeci®ed connective disorders are the most commonly identi®ed entities associated or coexistent with this disease. 1,3,5 ± 7 The aim of this study is to evaluate the involvement of systemic collagen disease in the pathophysiological process in patients with no identi®ed underlying cause.
Patients and methods

Patients
In this study, we divided the patients into two groups. The ®rst consisted of 30 successive patients who presented from January to July 1998 seeking treatment for erectile dysfunction related to Peyronie's disease diagnosed by history, clinical examination and complementary studies (X-ray and ultrasonography). The average age of this group was 58.3 y (range 35 to 74 y). The second group, consisting of 30 patients without Peyronie's disease who had no curvature of the penis, congenital or acquired, and who offered no history of trauma, served as the control group (Group 2). The mean age of patients in this group was 60.2 y (range 40 ± 79 y). All the patients were white and none had reported a history or clinical manifestations of collagen disease. The most important markers of collagen disease were obtained from all of the patients.
Rheumatoid factor
Rheumatoid factor (RF), an IgM antibody directed against the normal human IgG, was measured by rate nephelometry with the Behring Nefelometer 100 Analyzer in international units per milliliter. The test was considered normal if RF`10 IUamL. Waaler-Rose, an accurate rheumatoid hemagglutination test, was also used. The normal result for WaalerRose is not reactive.
Autoantibody screen
Identi®cation of serum human antinuclear antibodies (ANA) was performed by indirect immuno¯uorescence using rat liver as the substrate, the anti-human immunoglobulin reagent and¯uoro-chrome conjugate (HEP2). The normal result for this test is not reactive. LE cells also were screened, whether negative was the normal result.
Serological markers
Protein electrophoresis with the Beckman-Paragon instrument was used to measure various proteins in serum semiquantitatively, classifying them as albumin, alpha-1, alpha-2, beta and gamma globulins.
The normal values for protein electrophoresis ranges from 6.0 to 8.0 gadL for total proteins, 3.5 to 5.5 gadL for albumin, 0.2 to 0.4 gadL for alpha-1, 0.5 to 0.9 gadL for alpha-2, 0.6 to 1.1 gadL for beta and 0.7 to 1.5 gadL for gamma globulin. Mucoproteins and C-reactive protein were assessed as possible markers of immune activation. Mucoproteins was testes with the Microlab 200 instrument by the modi®ed Winzler's method. The normal results ranges from 2.0 to 4.5 mgadL. C-reactive protein assay was performed with the Behringer Turbitimer instrument by turbimetry and latex agglutination methods. The normal result for this test is`6.5 mgaL in agglutination and`5.0 mgaL in turbimetry.
Statistical analysis
Statistical analysis was performed using the chisquare test, with a 95% level of signi®cance (P`0.05).
Results
No difference in the mucoproteins levels was observed between patients with Peyronie's disease, who presented this marker altered in 66.7%, when compared with the patients of the control group, who showed alterations in 46.7% of the tests (P b 0.05). C-Reactive protein was altered in 23.3% of the Peyronie's disease patients and in 13.3% of the control patients but without any signi®cative difference (P b 0.05). No was observed either in the antinuclear antibody (ANA) determinations, reactive in 16.7% of the tested group and in 6.7% of the control group (P b 0.05). The rheumatoid factor was elevated in 6.7% of patients from both groups (P b 0.05). LE cells were normal in all the patients in our study (Table 1) . No statistical signi®cance between the two groups was found in the protein electrophoresis test (P b 0.05) ( Table 2 ). Only the Waaler-Rose test (rheumatoid hemagglutination test) was statistically higher in patients with Peyronie's disease in our study (P`0.05).
Discussion
Peyronie's disease is a localized scarring process that affects primarily the tunica albuginea and adjacent erectile tissue. 8 Fibrosis is a prominent feature in Peyronie's disease and is characterized by a process of replacement of normal tissue by mesenchymal cells and the extracellular matrix produced by these cells. 8 The excessive deposition of collagen gives rise to a plaque, which is initially ®brotic, and then, over time, can become calci®c.
Since its description, attributed to Francois Gigot de La Peyronie in the sixteenth century, several etiologies of the Peyronie's disease have been investigated: behavioral problems in conjugal relations, sexual transmitted disease (syphilis, gonorrhea), urine leakage proximal to a urethral stricture (causing cavernositis). 6 In the eighteenth century, several authors had associated the condition with syphilis and gonorrhea. 6, 9 The association with Dupuytren's palmar ®brosis was ®rst described by Albernethy. 9 Curling 10 in 1878, suggested that urine leakage proximal to a urethral stricture causing cavernositis could explain the disease in young men with this condition.
Bidgood 11 observed the disease in pilots burned in wartime with vascular access problems, who received transfusions through the penis.
In the nineteenth and twentieth centuries, most publications added gout, diabetes, urethral in¯am-mation, penile trauma, arthrosis, unspeci®ed connective disorders. 6 More recent associations have been made with microtrauma, ®broblastic hyperactivation, autoimmunity and HLA tissue type. 5 ElSakka et al 8 has demonstrated the involvement of TGF-b (transforming growth factor-b) in this disease. The TGF-b stimulates the synthesis of individual matrix components including ®broactin, tenascin, collagens and proteoglycans, while simultaneously blocking matrix degradation by decreasing proteases synthesis and increasing protease inhibitors. 8, 12 The true pathogenesis of Peyronie's disease is unknown despite several efforts to determine it: the autoimmune theory with Dupuytren's contracture, possible association of HLA markers association, trauma and infection. 5, 8 Chronic collagen disease was demonstrated with autoimmune disease. In particular, some classes of alleles appear to predispose to the development of certain autoimmune disorders, including insulindependent diabetes, rheumatoid arthritis and others. 5 Ralph et al 13 demonstrated a signi®cant elevation of the circulating antinuclear antibodies, hypergammaglobulinemia and antibody deposition in the plaque and cell immunity supporting an autoimmune basis for Peyronie's disease.
Its involvement with systemic collagen disease as analyzed in this study by the most common serum markers in patients with no underlying identi®ed process showed a lack of association in patients with Peyronie's disease when compared with a group of patients matched for age with no in¯ammatory diseases.
Furthermore, most series noted that the vast majority of cases were idiopathic and con®rm the lack of association of most cases with any pathological condition. 6 
